ISRG vs META: Which Is the Better Buy?

Side-by-side comparison of Intuitive Surgical, Inc. and Meta Platforms, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-29.
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+45.0% upside to fair value
Grade B High Quality
VS
Meta Platforms, Inc. Β· Communication Services
$671.34
+36.4% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+45.0%). META trades at a lower forward P/E (28.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ISRG META
Current Price $451.29 $671.34
Fair Value Estimate $654.37 $916.00
Upside to Fair Value +45.0% +36.4%
Market Cap $160.3B $1,698.2B
Forward P/E 53.8x 28.0x
EV / EBITDA 40.5x 16.5x
Price / Sales 15.2x 8.4x
Price / FCF 64.3x 36.8x
Revenue Growth YoY +23.0% +23.8%
Gross Margin 66.3% 82.0%
Operating Margin 30.5% 41.4%
Return on Equity 17.0% 30.6%
Dividend Yield 0% 0%
FCF Yield 1.55% 2.72%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
META β€” Meta Platforms, Inc.
Meta Platforms, Inc. operates a leading global social media and technology platform primarily through its Family of Apps segment, which generates over 98% of its $201 billion 2025 revenue, driven by strong advertising growth. The company maintains a high-quality business with a durable competitive moat supported by network effects, brand strength, and intangible assets, reflected in a 30.6% retur…
Accumulation Zones
Metric ISRG META
Zone Low $490.78 $687.00
Zone High $556.21 $778.60
In Buy Zone? Yes Yes
← ISRG Research    META Research β†’    All Research